CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: beauvericin
Accession: CHEBI:3000
browse the term
Definition: A trimeric cyclodepsipeptide composed from alternating methylphenylalanyl and hydroxyvaleryl residues.
Synonyms: exact_synonym: (3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
related_synonym: (3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-6,12,18-triisopropyl-4,10,16-trimethyl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone; Formula=C45H57N3O9; InChI=1S/C45H57N3O9/c1-28(2)37-40(49)46(7)35(26-32-21-15-11-16-22-32)44(53)56-39(30(5)6)42(51)48(9)36(27-33-23-17-12-18-24-33)45(54)57-38(29(3)4)41(50)47(8)34(43(52)55-37)25-31-19-13-10-14-20-31/h10-24,28-30,34-39H,25-27H2,1-9H3/t34-,35-,36-,37+,38+,39+/m0/s1; InChIKey=GYSCAQFHASJXRS-FFCOJMSVSA-N; SMILES=CC(C)[C@H]1OC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](OC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](OC(=O)[C@H](Cc2ccccc2)N(C)C1=O)C(C)C)C(C)C
xref: Beilstein:5223711; CAS:26048-05-5; KEGG:C11590; KNApSAcK:C00027924
xref_mesh: MESH:C004456
xref: PMID:12067253; PMID:15892576; PMID:16343425; PMID:18804027; PMID:18956271; PMID:23685117; PMID:23832252; PMID:24291394; PMID:24613870; PMID:24720681; PMID:25128875; PMID:25178661; PMID:25475336; PMID:25606862; PMID:25641103; Reaxys:24193536; Reaxys:5223711; Wikipedia:Beauvericin
G
Aatf
apoptosis antagonizing transcription factor
decreases expression
ISO
beauvericin results in decreased expression of AATF mRNA
CTD
PMID:29203277
NCBI chr10:69,299,029...69,392,207
Ensembl chr10:69,299,037...69,392,201
G
Abca1
ATP binding cassette subfamily A member 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ABCA1 mRNA
CTD
PMID:31100301
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abcg1
ATP binding cassette subfamily G member 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ABCG1 mRNA
CTD
PMID:31100301
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
G
Acat2
acetyl-CoA acetyltransferase 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ACAT2 protein
CTD
PMID:32407736
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
G
Acin1
apoptotic chromatin condensation inducer 1
decreases expression
ISO
beauvericin results in decreased expression of ACIN1 mRNA
CTD
PMID:29203277
NCBI chr15:28,102,112...28,147,001
Ensembl chr15:28,102,112...28,147,001
G
Acsl4
acyl-CoA synthetase long-chain family member 4
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ACSL4 protein
CTD
PMID:32407736
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
G
Actb
actin, beta
decreases expression
ISO
beauvericin results in decreased expression of ACTB mRNA
CTD
PMID:29203277
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Aen
apoptosis enhancing nuclease
decreases expression
ISO
beauvericin results in decreased expression of AEN mRNA
CTD
PMID:29203277
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
decreases expression
ISO
beauvericin results in decreased expression of AIFM1 mRNA
CTD
PMID:29203277
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Ak4
adenylate kinase 4
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of AK4 mRNA
CTD
PMID:31100301
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
G
Aldh5a1
aldehyde dehydrogenase 5 family, member A1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ALDH5A1 protein
CTD
PMID:32407736
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
G
Aldoa
aldolase, fructose-bisphosphate A
decreases expression
ISO
beauvericin results in decreased expression of ALDOA mRNA
CTD
PMID:29203277
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Anapc13
anaphase promoting complex subunit 13
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ANAPC13 protein
CTD
PMID:32407736
NCBI chr 8:103,205,520...103,213,936
Ensembl chr 8:103,205,520...103,213,936
G
Aprt
adenine phosphoribosyl transferase
decreases expression
ISO
beauvericin results in decreased expression of APRT mRNA
CTD
PMID:29203277
NCBI chr19:50,626,201...50,628,491
Ensembl chr19:50,626,202...50,628,431
G
Ar
androgen receptor
multiple interactions
ISO
beauvericin inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]
CTD
PMID:30716354
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arhgdia
Rho GDP dissociation inhibitor alpha
decreases expression
ISO
beauvericin results in decreased expression of ARHGDIA mRNA
CTD
PMID:29203277
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
G
Arpp21
cAMP regulated phosphoprotein 21
increases expression
ISO
beauvericin results in increased expression of ARPP21 mRNA
CTD
PMID:29203277
NCBI chr 8:112,034,636...112,199,273
Ensembl chr 8:112,034,642...112,194,297
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of ATP1A1 protein
CTD
PMID:32407736
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
G
Atp1a3
ATPase Na+/K+ transporting subunit alpha 3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ATP1A3 protein
CTD
PMID:32407736
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
G
Atp5pb
ATP synthase peripheral stalk-membrane subunit b
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ATP5PB protein
CTD
PMID:32407736
NCBI chr 2:193,424,138...193,435,418
Ensembl chr 2:193,424,047...193,435,418
G
Atp5pf
ATP synthase peripheral stalk subunit F6
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ATP5PF protein
CTD
PMID:32407736
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression multiple interactions
ISO
beauvericin results in decreased expression of BAX mRNA [zearalenol co-treated with beauvericin] results in increased expression of BAX mRNA
CTD
PMID:29203277 PMID:32956828
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
increases expression multiple interactions
ISO
beauvericin results in increased expression of BCL2 mRNA [zearalenol co-treated with beauvericin] results in increased expression of BCL2 mRNA
CTD
PMID:29203277 PMID:32956828
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Birc2
baculoviral IAP repeat-containing 2
increases expression
ISO
beauvericin results in increased expression of BIRC2 mRNA
CTD
PMID:29203277
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
ISO
beauvericin results in increased expression of BIRC3 mRNA
CTD
PMID:29203277
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Btf3l4
basic transcription factor 3-like 4
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of BTF3L4 protein
CTD
PMID:32407736
NCBI chr 5:123,567,902...123,587,527
Ensembl chr 5:123,567,907...123,586,866
G
C1qtnf3
C1q and TNF related 3
decreases expression
ISO
beauvericin results in decreased expression of C1QTNF3 mRNA
CTD
PMID:29203277
NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433
G
C1qtnf6
C1q and TNF related 6
increases expression
ISO
beauvericin results in increased expression of C1QTNF6 mRNA
CTD
PMID:29203277
NCBI chr 7:110,077,867...110,084,584
Ensembl chr 7:110,077,878...110,084,412
G
Caap1
caspase activity and apoptosis inhibitor 1
decreases expression
ISO
beauvericin results in decreased expression of CAAP1 mRNA
CTD
PMID:29203277
NCBI chr 5:109,313,253...109,414,323
Ensembl chr 5:109,361,912...109,414,314
G
Card11
caspase recruitment domain family, member 11
decreases expression
ISO
beauvericin results in decreased expression of CARD11 mRNA
CTD
PMID:29203277
NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112
G
Casp3
caspase 3
increases activity multiple interactions
EXP ISO
beauvericin results in increased activity of CASP3 protein [zearalenol co-treated with beauvericin] results in increased expression of CASP3 mRNA
CTD
PMID:25178661 PMID:32956828
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
increases activity
EXP
beauvericin results in increased activity of CASP7 protein
CTD
PMID:25178661
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
increases expression
ISO
beauvericin results in increased expression of CASP8 mRNA
CTD
PMID:29203277
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases expression
ISO
beauvericin results in increased expression of CASP9 mRNA
CTD
PMID:29203277
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccar2
cell cycle and apoptosis regulator 2
decreases expression
ISO
beauvericin results in decreased expression of CCAR2 mRNA
CTD
PMID:29203277
NCBI chr15:45,212,797...45,228,001
Ensembl chr15:45,212,803...45,227,636
G
Ccdc124
coiled-coil domain containing 124
decreases expression
ISO
beauvericin results in decreased expression of CCDC124 mRNA
CTD
PMID:29203277
NCBI chr16:18,566,745...18,572,564
Ensembl chr16:18,566,745...18,572,564
G
Ccdc180
coiled-coil domain containing 180
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CCDC180 protein
CTD
PMID:32407736
NCBI chr 5:60,154,883...60,223,508
Ensembl chr 5:60,154,910...60,223,522
G
Ccdc86
coiled-coil domain containing 86
decreases expression
ISO
beauvericin results in decreased expression of CCDC86 mRNA
CTD
PMID:29203277
NCBI chr 1:207,590,167...207,596,547
Ensembl chr 1:207,590,168...207,596,544
G
Ccng2
cyclin G2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CCNG2 mRNA
CTD
PMID:31100301
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Cct5
chaperonin containing TCP1 subunit 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CCT5 protein
CTD
PMID:32407736
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
G
Cd47
Cd47 molecule
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CD47 protein
CTD
PMID:32407736
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
G
Cd81
Cd81 molecule
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CD81 protein
CTD
PMID:32407736
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
G
Cdk2ap2
cyclin-dependent kinase 2 associated protein 2
decreases expression
ISO
beauvericin results in decreased expression of CDK2AP2 mRNA
CTD
PMID:29203277
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
G
Cebpb
CCAAT/enhancer binding protein beta
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CEBPB mRNA
CTD
PMID:31100301
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Cflar
CASP8 and FADD-like apoptosis regulator
increases expression
ISO
beauvericin results in increased expression of CFLAR mRNA
CTD
PMID:29203277
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
G
Chchd2
coiled-coil-helix-coiled-coil-helix domain containing 2
decreases expression
ISO
beauvericin results in decreased expression of CHCHD2 mRNA
CTD
PMID:29203277
NCBI chr12:26,828,738...26,834,762
Ensembl chr12:26,828,736...26,834,755
G
Ciapin1
cytokine induced apoptosis inhibitor 1
decreases expression
ISO
beauvericin results in decreased expression of CIAPIN1 mRNA
CTD
PMID:29203277
NCBI chr19:10,179,963...10,195,511
Ensembl chr19:10,180,100...10,195,503
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CNP protein
CTD
PMID:32407736
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
G
Coa6
cytochrome c oxidase assembly factor 6
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of COA6 protein
CTD
PMID:32407736
NCBI chr19:54,395,746...54,398,348
Ensembl chr19:54,395,742...54,399,407
G
Coro1c
coronin 1C
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CORO1C protein
CTD
PMID:32407736
NCBI chr12:42,713,024...42,785,179
Ensembl chr12:42,712,991...42,785,179
G
Cotl1
coactosin-like F-actin binding protein 1
decreases expression
ISO
beauvericin results in decreased expression of COTL1 mRNA
CTD
PMID:29203277
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
G
Cplane2
ciliogenesis and planar polarity effector complex subunit 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of CPLANE2 protein
CTD
PMID:32407736
NCBI chr 5:153,515,507...153,516,455
Ensembl chr 5:153,515,376...153,522,508
G
Cpne1
copine 1
decreases expression
ISO
beauvericin results in decreased expression of CPNE1 mRNA
CTD
PMID:29203277
NCBI chr 3:144,587,531...144,629,911
Ensembl chr 3:144,588,995...144,598,636
G
Crim1
cysteine rich transmembrane BMP regulator 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CRIM1 mRNA
CTD
PMID:31100301
NCBI chr 6:16,695,864...16,870,264
Ensembl chr 6:16,697,829...16,870,259
G
Csdc2
cold shock domain containing C2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CSDC2 protein
CTD
PMID:32407736
NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463
G
Csk
C-terminal Src kinase
decreases expression
ISO
beauvericin results in decreased expression of CSK mRNA
CTD
PMID:29203277
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
G
Ctps1
CTP synthase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CTPS1 protein
CTD
PMID:32407736
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
G
Ctsd
cathepsin D
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CTSD protein
CTD
PMID:32407736
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
G
Cyp4f39
cytochrome P450, family 4, subfamily f, polypeptide 39
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of CYP4F22 protein
CTD
PMID:32407736
NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181
G
Dcxr
dicarbonyl and L-xylulose reductase
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of DCXR protein
CTD
PMID:32407736
NCBI chr10:106,006,404...106,008,293
G
Ddias
DNA damage-induced apoptosis suppressor
decreases expression
ISO
beauvericin results in decreased expression of DDIAS mRNA
CTD
PMID:29203277
NCBI chr 1:146,906,150...146,930,462
Ensembl chr 1:146,906,154...146,930,462
G
Ddx47
DEAD-box helicase 47
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of DDX47 protein
CTD
PMID:32407736
NCBI chr 4:167,845,652...167,858,115
Ensembl chr 4:167,845,640...167,859,115
G
Dhrs7
dehydrogenase/reductase 7
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of DHRS7 protein
CTD
PMID:32407736
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
increases expression
ISO
beauvericin results in increased expression of EDEM1 mRNA
CTD
PMID:29203277
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
G
Eif5a
eukaryotic translation initiation factor 5A
decreases expression
ISO
beauvericin results in decreased expression of EIF5A mRNA
CTD
PMID:29203277
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
G
Faim2
Fas apoptotic inhibitory molecule 2
increases expression
ISO
beauvericin results in increased expression of FAIM2 mRNA
CTD
PMID:29203277
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
G
Fmc1
formation of mitochondrial complex V assembly factor 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of FMC1 protein
CTD
PMID:32407736
NCBI chr 4:67,274,104...67,282,140
Ensembl chr 4:67,274,104...67,282,140
G
Gaa
alpha glucosidase
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of GAA protein
CTD
PMID:32407736
NCBI chr10:104,529,673...104,546,836
Ensembl chr10:104,529,747...104,546,836
G
Gna14
G protein subunit alpha 14
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of GNA14 protein
CTD
PMID:32407736
NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423
G
Gnai3
G protein subunit alpha i3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of GNAI3 protein
CTD
PMID:32407736
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
G
Gnb1
G protein subunit beta 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of GNB1 protein
CTD
PMID:32407736
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
G
Golga1
golgin A1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of GOLGA1 protein
CTD
PMID:32407736
NCBI chr 3:22,765,690...22,812,637
Ensembl chr 3:22,767,761...22,812,585
G
Gpnmb
glycoprotein nmb
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of GPNMB protein
CTD
PMID:32407736
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpr18
G protein-coupled receptor 18
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of GPR18 mRNA
CTD
PMID:31100301
NCBI chr15:98,997,427...99,001,177
Ensembl chr15:98,997,259...99,001,470
G
Hexb
hexosaminidase subunit beta
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of HEXB protein
CTD
PMID:32407736
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
G
Hist2h2be
histone cluster 2 H2B family member E
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of HIST2H2BE protein
CTD
PMID:32407736
NCBI chr 2:183,780,583...183,783,030
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of HMGCS1 mRNA
CTD
PMID:31100301
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hnrnpm
heterogeneous nuclear ribonucleoprotein M
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of HNRNPM protein
CTD
PMID:32407736
NCBI chr 7:14,438,703...14,476,781
Ensembl chr 7:14,438,688...14,476,762
G
Hnrnpu
heterogeneous nuclear ribonucleoprotein U
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of HNRNPU protein
CTD
PMID:32407736
NCBI chr13:90,069,058...90,086,905
Ensembl chr13:90,074,181...90,086,588
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of HSPA5 mRNA
CTD
PMID:31100301
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Immt
inner membrane mitochondrial protein
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of IMMT protein
CTD
PMID:32407736
NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109
G
Insig1
insulin induced gene 1
increases expression
ISO
beauvericin results in increased expression of INSIG1 mRNA
CTD
PMID:29203277
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Islr2
immunoglobulin superfamily containing leucine-rich repeat 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of ISLR2 protein
CTD
PMID:32407736
NCBI chr 8:58,608,165...58,616,246
Ensembl chr 8:58,608,709...58,614,650
G
Itgb1
integrin subunit beta 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of ITGB1 protein
CTD
PMID:32407736
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
G
Klf12
KLF transcription factor 12
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of KLF12 protein
CTD
PMID:32407736
NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056
G
Kpnb1
karyopherin subunit beta 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of KPNB1 protein
CTD
PMID:32407736
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
G
Krt16
keratin 16
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of KRT16 protein
CTD
PMID:32407736
NCBI chr10:85,168,357...85,171,816
Ensembl chr10:85,066,802...85,171,799
G
Krt27
keratin 27
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of KRT27 protein
CTD
PMID:32407736
NCBI chr10:84,298,684...84,303,967
Ensembl chr10:84,298,508...84,303,967
G
Krt5
keratin 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of KRT5 protein
CTD
PMID:32407736
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
G
Krt76
keratin 76
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of KRT76 protein
CTD
PMID:32407736
NCBI chr 7:133,016,990...133,025,475
Ensembl chr 7:133,016,992...133,025,496
G
Lamp2
lysosomal-associated membrane protein 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of LAMP2 protein
CTD
PMID:32407736
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
G
Lat
linker for activation of T cells
decreases expression
ISO
beauvericin results in decreased expression of LAT mRNA
CTD
PMID:29203277
NCBI chr 1:180,936,536...180,941,561
Ensembl chr 1:180,936,534...180,941,578
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
EXP
beauvericin results in decreased phosphorylation of MAPK1 protein
CTD
PMID:25178661
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation
EXP
beauvericin results in decreased phosphorylation of MAPK3 protein
CTD
PMID:25178661
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Matn4
matrilin 4
decreases expression
ISO
beauvericin results in decreased expression of MATN4 mRNA
CTD
PMID:29203277
NCBI chr 3:153,120,605...153,135,628
Ensembl chr 3:153,120,632...153,135,865
G
Mavs
mitochondrial antiviral signaling protein
increases expression
ISO
beauvericin results in increased expression of MAVS mRNA
CTD
PMID:29203277
NCBI chr 3:118,451,650...118,466,094
Ensembl chr 3:118,451,743...118,466,094
G
Med6
mediator complex subunit 6
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of MED6 protein
CTD
PMID:32407736
NCBI chr 6:101,270,410...101,283,929
Ensembl chr 6:101,270,410...101,283,876
G
Moap1
modulator of apoptosis 1
increases expression
ISO
beauvericin results in increased expression of MOAP1 mRNA
CTD
PMID:29203277
NCBI chr 6:121,882,565...121,884,500
Ensembl chr 6:121,882,366...121,898,643
G
Mrpl12
mitochondrial ribosomal protein L12
decreases expression multiple interactions
ISO
beauvericin results in decreased expression of MRPL12 mRNA [beauvericin co-treated with enniatins] results in decreased expression of MRPL12 mRNA
CTD
PMID:29203277 PMID:31100301
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
G
Mrpl4
mitochondrial ribosomal protein L4
decreases expression
ISO
beauvericin results in decreased expression of MRPL4 mRNA
CTD
PMID:29203277
NCBI chr 8:19,539,593...19,545,608
Ensembl chr 8:19,539,593...19,545,608
G
Mt-atp6
mitochondrially encoded ATP synthase membrane subunit 6
decreases expression multiple interactions
ISO
beauvericin results in decreased expression of ATP6 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ATP6 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ATP6 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ATP6 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of ATP6 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of ATP6 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP6 mRNA
CTD
PMID:29203277 PMID:31100301 PMID:34015425
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
G
Mt-atp8
mitochondrially encoded ATP synthase membrane subunit 8
decreases expression multiple interactions
ISO
beauvericin results in decreased expression of ATP8 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ATP8 mRNA; [beauvericin co-treated with enniatins] affects the expression of ATP8 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP8 mRNA
CTD
PMID:29203277 PMID:31100301 PMID:34015425
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
multiple interactions decreases expression
ISO
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX1 mRNA; [beauvericin co-treated with enniatins] affects the expression of COX1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX1 mRNA beauvericin results in decreased expression of COX1 mRNA
CTD
PMID:31100301 PMID:34015425
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Mt-co3
mitochondrially encoded cytochrome c oxidase III
decreases expression multiple interactions
ISO
beauvericin results in decreased expression of COX3 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX3 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX3 mRNA
CTD
PMID:29203277 PMID:31100301 PMID:34015425
NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
G
Mt-cyb
mitochondrially encoded cytochrome b
decreases expression
ISO
beauvericin results in decreased expression of CYTB mRNA
CTD
PMID:29203277
NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
G
Mt-nd2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
decreases expression multiple interactions increases expression
ISO
beauvericin results in decreased expression of ND2 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND2 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND2 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND2 mRNA beauvericin results in increased expression of ND2 mRNA
CTD
PMID:29203277 PMID:31100301 PMID:34015425
NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
G
Mt-nd3
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3
decreases expression multiple interactions increases expression
ISO
beauvericin results in decreased expression of ND3 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND3 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND3 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND3 mRNA beauvericin results in increased expression of ND3 mRNA
CTD
PMID:29203277 PMID:31100301 PMID:34015425
NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798
Ensembl chr MT:9,451...9,798
G
Mt-nd4
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4
decreases expression multiple interactions
ISO
beauvericin results in decreased expression of ND4 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND4 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND4 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ND4 mRNA
CTD
PMID:29203277 PMID:31100301 PMID:34015425
NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537
Ensembl chr MT:10,160...11,537
G
Mt-nd4l
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L
decreases expression multiple interactions increases expression
ISO
beauvericin results in decreased expression of ND4L mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND4L mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND4L mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND4L mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND4L mRNA beauvericin results in increased expression of ND4L mRNA
CTD
PMID:29203277 PMID:31100301 PMID:34015425
NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166
Ensembl chr MT:9,870...10,166
G
Mt-nd5
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5
decreases expression multiple interactions increases expression
ISO
beauvericin results in decreased expression of ND5 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND5 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND5 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND5 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND5 mRNA beauvericin results in increased expression of ND5 mRNA
CTD
PMID:29203277 PMID:31100301 PMID:34015425
NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
G
Mt-nd6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
decreases expression multiple interactions
ISO
beauvericin results in decreased expression of ND6 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND6 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND6 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND6 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND6 mRNA
CTD
PMID:34015425
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
G
Mtrf1l
mitochondrial translation release factor 1 like
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of MTRF1L protein
CTD
PMID:32407736
NCBI chr 1:42,208,553...42,221,020
Ensembl chr 1:42,210,583...42,220,836
G
Myo18a
myosin XVIIIa
increases expression
ISO
beauvericin results in increased expression of MYO18A mRNA
CTD
PMID:29203277
NCBI chr10:62,654,218...62,755,465
Ensembl chr10:62,654,281...62,755,468
G
Nars1
asparaginyl-tRNA synthetase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of NARS1 protein
CTD
PMID:32407736
NCBI chr18:57,989,308...58,005,584
Ensembl chr18:57,989,308...58,005,622
G
Nars2
asparaginyl-tRNA synthetase 2, mitochondrial
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of NARS2 protein
CTD
PMID:32407736
NCBI chr 1:151,300,446...151,412,086
Ensembl chr 1:151,300,467...151,413,521
G
Ndrg1
N-myc downstream regulated 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of NDRG1 protein
CTD
PMID:32407736
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Nlrp1a
NLR family, pyrin domain containing 1A
increases expression
ISO
beauvericin results in increased expression of NLRP1 mRNA
CTD
PMID:29203277
NCBI chr10:55,778,560...55,833,639
Ensembl chr10:55,778,560...55,825,180
G
Nod1
nucleotide-binding oligomerization domain containing 1
increases expression
ISO
beauvericin results in increased expression of NOD1 mRNA
CTD
PMID:29203277
NCBI chr 4:84,060,871...84,111,668
Ensembl chr 4:84,060,880...84,111,404
G
Nol3
nucleolar protein 3
increases expression
ISO
beauvericin results in increased expression of NOL3 mRNA
CTD
PMID:29203277
NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of NQO1 mRNA
CTD
PMID:31100301
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nudt1
nudix hydrolase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of NUDT1 protein
CTD
PMID:32407736
NCBI chr12:14,302,514...14,309,559
Ensembl chr12:14,302,694...14,305,826
G
Oga
O-GlcNAcase
increases expression
ISO
beauvericin results in increased expression of OGA mRNA
CTD
PMID:29203277
NCBI chr 1:244,598,285...244,633,835
Ensembl chr 1:244,598,292...244,634,359
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
increases expression
ISO
beauvericin results in increased expression of OGT mRNA
CTD
PMID:29203277
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
G
Osgin1
oxidative stress induced growth inhibitor 1
multiple interactions increases expression
ISO
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of OSGIN1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of OSGIN1 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of OSGIN1 mRNA beauvericin results in increased expression of OSGIN1 mRNA
CTD
PMID:31100301 PMID:34015425
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
G
Ostc
oligosaccharyltransferase complex non-catalytic subunit
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of OSTC protein
CTD
PMID:32407736
NCBI chr 2:219,250,549...219,266,076
Ensembl chr 2:219,236,952...219,266,107
G
Parvg
parvin, gamma
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PARVG protein
CTD
PMID:32407736
NCBI chr 7:115,456,183...115,475,707
Ensembl chr 7:115,456,209...115,475,104
G
Pawr
pro-apoptotic WT1 regulator
decreases expression
ISO
beauvericin results in decreased expression of PAWR mRNA
CTD
PMID:29203277
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
G
Pdcd11
programmed cell death 11
decreases expression
ISO
beauvericin results in decreased expression of PDCD11 mRNA
CTD
PMID:29203277
NCBI chr 1:245,980,840...246,021,999
Ensembl chr 1:245,980,880...246,021,999
G
Pdcd2
programmed cell death 2
decreases expression
ISO
beauvericin results in decreased expression of PDCD2 mRNA
CTD
PMID:29203277
NCBI chr 1:56,484,947...56,490,437
Ensembl chr 1:56,463,931...56,490,437
G
Pdcd2l
programmed cell death 2-like
increases expression
ISO
beauvericin results in increased expression of PDCD2L mRNA
CTD
PMID:29203277
NCBI chr 1:86,810,292...86,822,554
Ensembl chr 1:86,810,292...86,822,554
G
Pdcd4
programmed cell death 4
decreases expression
ISO
beauvericin results in decreased expression of PDCD4 mRNA
CTD
PMID:29203277
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
G
Pdcd5
programmed cell death 5
increases expression
ISO
beauvericin results in increased expression of PDCD5 mRNA
CTD
PMID:29203277
NCBI chr 1:88,305,869...88,311,200
Ensembl chr 1:88,305,869...88,311,200
G
Pdcd6ip
programmed cell death 6 interacting protein
increases expression
ISO
beauvericin results in increased expression of PDCD6IP mRNA
CTD
PMID:29203277
NCBI chr 8:113,590,998...113,646,795
Ensembl chr 8:113,590,998...113,646,773
G
Pdia4
protein disulfide isomerase family A, member 4
decreases expression
ISO
beauvericin results in decreased expression of PDIA4 mRNA
CTD
PMID:29203277
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pfn1
profilin 1
decreases expression multiple interactions
ISO
beauvericin results in decreased expression of PFN1 mRNA [beauvericin co-treated with enniatins] results in increased expression of PFN1 protein
CTD
PMID:29203277 PMID:32407736
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
G
Pgam1
phosphoglycerate mutase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PGAM1 protein
CTD
PMID:32407736
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
G
Pgk1
phosphoglycerate kinase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PGK1 protein
CTD
PMID:32407736
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
G
Phgdh
phosphoglycerate dehydrogenase
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PHGDH protein
CTD
PMID:32407736
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Phka2
phosphorylase kinase regulatory subunit alpha 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of PHKA2 protein
CTD
PMID:32407736
NCBI chr X:34,170,959...34,293,498
Ensembl chr X:34,171,323...34,293,466
G
Pidd1
p53-induced death domain protein 1
decreases expression
ISO
beauvericin results in decreased expression of PIDD1 mRNA
CTD
PMID:29203277
NCBI chr 1:196,536,815...196,542,808
Ensembl chr 1:196,536,834...196,542,699
G
Plk1
polo-like kinase 1
decreases expression
ISO
beauvericin results in decreased expression of PLK1 mRNA
CTD
PMID:29203277
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
G
Pls3
plastin 3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of PLS3 protein
CTD
PMID:32407736
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
G
Ppa1
inorganic pyrophosphatase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PPA1 protein
CTD
PMID:32407736
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
G
Ppan
peter pan homolog
decreases expression
ISO
beauvericin results in decreased expression of PPAN mRNA
CTD
PMID:29203277
NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938
G
Ppib
peptidylprolyl isomerase B
decreases expression
ISO
beauvericin results in decreased expression of PPIB mRNA
CTD
PMID:29203277
NCBI chr 8:66,603,877...66,609,734
Ensembl chr 8:66,603,861...66,630,428
G
Ppp1r14b
protein phosphatase 1, regulatory (inhibitor) subunit 14B
decreases expression
ISO
beauvericin results in decreased expression of PPP1R14B mRNA
CTD
PMID:29203277
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319
G
Ppt1
palmitoyl-protein thioesterase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of PPT1 protein
CTD
PMID:32407736
NCBI chr 5:135,121,164...135,142,048
Ensembl chr 5:135,121,163...135,142,048
G
Prkca
protein kinase C, alpha
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PRKCA protein
CTD
PMID:32407736
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Psma5
proteasome 20S subunit alpha 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PSMA5 protein
CTD
PMID:32407736
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731
G
Psme4
proteasome activator subunit 4
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of PSME4 protein
CTD
PMID:32407736
NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408
G
Ptges3
prostaglandin E synthase 3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PTGES3 protein
CTD
PMID:32407736
NCBI chr 7:490,698...507,759
Ensembl chr 7:490,656...508,084
G
Ptprc
protein tyrosine phosphatase, receptor type, C
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of PTPRC protein
CTD
PMID:32407736
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
G
Rab11fip5
RAB11 family interacting protein 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of RAB11FIP5 protein
CTD
PMID:32407736
NCBI chr 4:117,871,301...117,908,819
Ensembl chr 4:117,871,308...117,908,741
G
Rab5a
RAB5A, member RAS oncogene family
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RAB5A protein
CTD
PMID:32407736
NCBI chr 9:6,483,906...6,512,877
Ensembl chr 9:6,484,469...6,512,873
G
Rac3
Rac family small GTPase 3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RAC3 protein
CTD
PMID:32407736
NCBI chr10:106,002,808...106,005,243
Ensembl chr10:105,993,087...106,005,260
G
Rap1a
RAP1A, member of RAS oncogene family
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RAP1A protein
CTD
PMID:32407736
NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
G
Relt
RELT, TNF receptor
decreases expression
ISO
beauvericin results in decreased expression of RELT mRNA
CTD
PMID:29203277
NCBI chr 1:155,206,976...155,224,609
Ensembl chr 1:155,206,976...155,214,196
G
Rp2
RP2 activator of ARL3 GTPase
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RP2 protein
CTD
PMID:32407736
NCBI chr X:1,872,582...1,916,704
Ensembl chr X:1,873,306...1,916,688
G
Rpl37a
ribosomal protein L37A
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RPL37A protein
CTD
PMID:32407736
NCBI chr 9:74,298,843...74,300,926
G
Rpl5
ribosomal protein L5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RPL5 protein
CTD
PMID:32407736
NCBI chr14:1,843,856...1,850,301
Ensembl chr14:1,843,770...1,850,290
G
Rpl8
ribosomal protein L8
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of RPL8 protein
CTD
PMID:32407736
NCBI chr 7:108,626,194...108,628,485
Ensembl chr 7:108,622,324...108,628,482 Ensembl chr 3:108,622,324...108,628,482
G
Rxra
retinoid X receptor alpha
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of RXRA protein
CTD
PMID:32407736
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Scml2
Scm polycomb group protein like 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of SCML2 protein
CTD
PMID:32407736
NCBI chr X:33,523,179...33,677,672
Ensembl chr X:33,524,530...33,652,742
G
Sdf2l1
stromal cell-derived factor 2-like 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of SDF2L1 protein
CTD
PMID:32407736
NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902
G
Sdr42e2
short chain dehydrogenase/reductase family 42E, member 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SDR42E2 protein
CTD
PMID:32407736
NCBI chr 1:175,361,630...175,382,769
Ensembl chr 1:175,362,150...175,382,050
G
Sec13
SEC13 homolog, nuclear pore and COPII coat complex component
decreases expression
ISO
beauvericin results in decreased expression of SEC13 mRNA
CTD
PMID:29203277
NCBI chr 4:146,877,739...146,891,130
Ensembl chr 4:146,875,524...146,891,173
G
Siva1
SIVA1, apoptosis-inducing factor
decreases expression
ISO
beauvericin results in decreased expression of SIVA1 mRNA
CTD
PMID:29203277
NCBI chr 6:131,705,323...131,709,697
Ensembl chr 6:131,705,323...131,709,690
G
Slc1a5
solute carrier family 1 member 5
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SLC1A5 protein
CTD
PMID:32407736
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc2a1
solute carrier family 2 member 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SLC2A1 protein
CTD
PMID:32407736
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc3a2
solute carrier family 3 member 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SLC3A2 protein
CTD
PMID:32407736
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Snrpd2
small nuclear ribonucleoprotein D2 polypeptide
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SNRPD2 protein
CTD
PMID:32407736
NCBI chr 1:78,798,377...78,801,227
Ensembl chr 1:78,798,377...78,803,351
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of SNRPD3 protein
CTD
PMID:32407736
NCBI chr20:13,130,112...13,145,947
Ensembl chr20:13,130,119...13,145,978
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
decreases activity
EXP
beauvericin results in decreased activity of SRC protein
CTD
PMID:25178661
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Srm
spermidine synthase
decreases expression
ISO
beauvericin results in decreased expression of SRM mRNA
CTD
PMID:29203277
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
G
Srsf7
serine and arginine rich splicing factor 7
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of SRSF7 protein
CTD
PMID:32407736
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
G
Srxn1
sulfiredoxin 1
multiple interactions decreases expression
ISO
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of SRXN1 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of SRXN1 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of SRXN1 mRNA beauvericin results in decreased expression of SRXN1 mRNA
CTD
PMID:31100301 PMID:34015425
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Ssbp1
single stranded DNA binding protein 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of SSBP1 protein
CTD
PMID:32407736
NCBI chr 4:69,266,024...69,276,135
Ensembl chr 4:69,266,102...69,276,135
G
Tbc1d2b
TBC1 domain family, member 2B
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TBC1D2B protein
CTD
PMID:32407736
NCBI chr 8:90,746,220...90,814,867
Ensembl chr 8:90,746,233...90,814,832
G
Tcn2
transcobalamin 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TCN2 protein
CTD
PMID:32407736
NCBI chr14:78,813,343...78,828,549
Ensembl chr14:78,813,343...78,828,489
G
Tcp11l1
t-complex 11 like 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TCP11L1 protein
CTD
PMID:32407736
NCBI chr 3:91,047,006...91,092,687
Ensembl chr 3:90,998,270...91,092,006
G
Tcp11l2
t-complex 11 like 2
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TCP11L2 protein
CTD
PMID:32407736
NCBI chr 7:19,150,241...19,185,135
Ensembl chr 7:19,150,252...19,185,095
G
Thyn1
thymocyte nuclear protein 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of THYN1 protein
CTD
PMID:32407736
NCBI chr 8:25,406,563...25,415,445
Ensembl chr 8:25,406,500...25,415,445
G
Timm9
translocase of inner mitochondrial membrane 9
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TIMM9 protein
CTD
PMID:32407736
NCBI chr 6:89,610,094...89,622,924
Ensembl chr 6:89,610,094...89,622,924
G
Tk1
thymidine kinase 1
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TK1 protein
CTD
PMID:32407736
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tmem263
transmembrane protein 263
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of TMEM263 protein
CTD
PMID:32407736
NCBI chr 7:18,610,151...18,628,311
Ensembl chr 7:18,610,149...18,628,534
G
Tnfsf10
TNF superfamily member 10
decreases expression
ISO
beauvericin results in decreased expression of TNFSF10 mRNA
CTD
PMID:29203277
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tomm22
translocase of outer mitochondrial membrane 22
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TOMM22 protein
CTD
PMID:32407736
NCBI chr 7:111,223,508...111,228,671
Ensembl chr 7:111,216,571...111,246,799
G
Tomm7
translocase of outer mitochondrial membrane 7
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of TOMM7 protein
CTD
PMID:32407736
NCBI chr 4:11,305,122...11,311,963
Ensembl chr 4:11,305,110...11,311,962
G
Tuba1b
tubulin, alpha 1B
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of TUBA1B protein
CTD
PMID:32407736
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
G
Tubb3
tubulin, beta 3 class III
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of TUBB3 protein
CTD
PMID:32407736
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
G
Tubb4a
tubulin, beta 4A class IVa
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of TUBB4A protein
CTD
PMID:32407736
NCBI chr 9:1,917,841...1,925,286
Ensembl chr 9:1,917,845...1,925,291
G
Tubb4b
tubulin, beta 4B class IVb
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of TUBB4B protein
CTD
PMID:32407736
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of TUBB protein
CTD
PMID:32407736
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Txnip
thioredoxin interacting protein
increases expression decreases expression multiple interactions
ISO
beauvericin results in increased expression of TXNIP mRNA beauvericin results in decreased expression of TXNIP mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of TXNIP mRNA
CTD
PMID:29203277 PMID:34015425
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Ucp2
uncoupling protein 2
multiple interactions decreases expression
ISO
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of UCP2 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of UCP2 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of UCP2 mRNA beauvericin results in decreased expression of UCP2 mRNA
CTD
PMID:31100301 PMID:34015425
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ucp3
uncoupling protein 3
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in decreased expression of UCP3 mRNA
CTD
PMID:31100301
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
G
Ybx1
Y box binding protein 1
decreases expression
ISO
beauvericin results in decreased expression of YBX1 mRNA
CTD
PMID:29203277
NCBI chr 5:132,882,137...132,898,885
Ensembl chr 5:132,882,145...132,898,862
G
Ybx3
Y box binding protein 3
decreases expression
ISO
beauvericin results in decreased expression of YBX3 mRNA
CTD
PMID:29203277
NCBI chr 4:165,129,747...165,153,101
Ensembl chr 4:165,129,758...165,153,161
G
Ykt6
YKT6 v-SNARE homolog
multiple interactions
ISO
[beauvericin co-treated with enniatins] results in increased expression of YKT6 protein
CTD
PMID:32407736
NCBI chr14:80,832,187...80,843,394
Ensembl chr14:80,832,187...80,843,385
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all